2m 2m 2m 2m 2m 2m 2m
RIGEL PHARM (RIGL)
NASDAQ
$30.88+$0.86 (+2.85%)
Price as of Jun 03, 2026 4:23 PM EDT- $564.1MMarket Cap
- 47.23%1-Year Change
- BiotechnologyIndustry
RIGEL PHARM (RIGL)
$30.88+$0.86 (+2.85%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 232.0M +29.40% | 179.3M +53.38% | 116.9M -2.79% | 120.2M -19.43% | |
Cost of Revenue | 19.6M +5.22% | 18.6M +162.26% | 7.1M +306.52% | 1.7M +61.50% | |
Gross Profit | 212.4M +32.20% | 160.6M +46.33% | 109.8M -7.36% | 118.5M -20.02% | |
Sales and Marketing Expense | 115.9M +2.51% | 113.1M +6.92% | 105.7M -5.97% | 112.5M +22.37% | |
Research and Development Expense | -33.3M +42.41% | -23.4M -4.66% | -24.5M -59.31% | -60.3M -7.61% | |
Depreciation and Amortization Expense | 2.4M +8.39% | 2.2M +79.97% | 1.2M +24.05% | 998,000 -14.11% | |
Total Operating Expenses | 168.8M +8.85% | 155.1M +12.89% | 137.4M -21.85% | 175.8M +8.69% | |
Operating Profit | 125.5M +418.63% | 24.2M +218.06% | -20.5M -63.11% | -55.5M +344.54% | |
Interest Income | 3.7M +75.96% | 2.1M -7.92% | 2.3M +232.16% | 684,000 +1,355.32% | |
Interest Expense | -3.6M -54.04% | -7.9M +15.22% | -6.9M +85.38% | -3.7M -23.72% | |
Interest Income and Expense and Net | 42,000 +100.72% | -5.8M +26.65% | -4.6M +52.17% | -3.0M -37.19% | |
Total Nonoperating Income and Expense | -3.6M -145.96% | 7.9M +15.22% | 6.9M +85.38% | 3.7M -23.72% | |
Income before Taxes | 121.8M +563.33% | 18.4M +173.20% | -25.1M -57.16% | -58.6M +238.40% | |
Income Taxes | -245.2M -27,931.67% | 881,000 +45.62% | 605,000 0.00% | 605,000 0.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 367.0M +1,999.08% | 17.5M +169.69% | -25.1M -57.16% | -58.6M +226.97% | |
Net Income from Continuing Operations Applicable to Common | 121.8M +563.33% | 18.4M +173.20% | -25.1M -57.16% | -58.6M +238.40% | |
Basic EPS and Net Income | 20.40 +1,960.61% | 0.99 +807.14% | -0.14 -58.82% | -0.34 +209.09% | |
Diluted EPS and Net Income | 19.48 +1,867.68% | 0.99 +807.14% | -0.14 -58.82% | -0.34 +209.09% | |
Basic Weighted Average Shares | 18.0M +2.32% | 17.6M -89.90% | 174.0M +0.93% | 172.4M +1.12% | |
Diluted Weighted Average Shares | 18.8M +6.52% | 17.7M -89.84% | 174.0M +0.93% | 172.4M +1.12% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 40.6M -28.49% | 56.7M +73.08% | 32.8M +34.04% | 24.5M +29.48% | |
Short-Term Investments | 114.4M +455.89% | 20.6M -14.79% | 24.1M -28.45% | 33.7M -68.19% | |
Cash and Cash Equivalents and Short-Term Investments | 155.0M +100.40% | 77.3M +35.81% | 56.9M -2.19% | 58.2M -53.42% | |
Total Current Assets | 240.2M +77.77% | 135.1M +36.10% | 99.3M -14.35% | 115.9M -24.97% | |
Accumulated Depreciation | 317,000 +21.46% | 261,000 -84.68% | 1.7M -84.23% | 10.8M -25.73% | |
Property and Plant and Equipment and Net | 30,000 -67.39% | 92,000 -44.24% | 165,000 -80.75% | 857,000 -60.76% | |
Total Long-Term Assets | 1.9M +32.96% | 1.4M -53.03% | 3.1M +377.34% | 640,000 -34.29% | |
Total Assets | 513.6M +213.21% | 164.0M +39.88% | 117.2M -12.70% | 134.3M -19.75% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 29.8M +309.96% | 7.3M +0.59% | 7.2M N/A | N/A N/A | |
Total Current Liabilities | 99.2M +56.77% | 63.3M +18.83% | 53.3M -18.32% | 65.2M +2.61% | |
Total Long-Term Debt | 22.5M -57.10% | 52.4M +0.07% | 52.4M +32.76% | 39.4M +98.09% | |
Total Long-Term Liabilities | 0 -100.00% | 40.0M +0.09% | 39.9M -5.49% | 42.3M -19.84% | |
Total Liabilities | 122.1M -24.01% | 160.7M +10.16% | 145.9M -1.37% | 147.9M +129.96% | |
Retained Earnings | -1.0B -26.40% | -1.4B -1.24% | -1.4B +1.81% | -1.4B +4.42% | |
Total Stockholders Equity | 391.5M +11,806.33% | 3.3M +111.48% | -28.6M +110.37% | -13.6M -144.83% | |
Total Shares Outstanding | 18.3M +3.39% | 17.7M -89.87% | 174.8M +0.82% | 173.4M +1.05% | |
Cash Flow | |||||
Cash from Operating Activities | 75.7M +140.40% | 31.5M +647.99% | -5.7M -92.21% | -73.8M -1,354.81% | |
Capital Expenditures | N/A N/A | N/A N/A | 450,000 0.00% | 450,000 -28.23% | |
Cash from Investing Activities | -92.4M -2,336.44% | 4.1M +196.11% | -4.3M -105.90% | 72.8M +190.93% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 601,000 +105.16% | -11.6M -163.38% | 18.4M +180.41% | 6.5M -89.55% | |
Financials Ratio | |||||
Gross Margin | 91.54% +2.17% | 89.60% -4.60% | 93.92% -4.70% | 98.55% -0.73% | |
Operating Margin | 54.08% +300.80% | 13.49% +176.97% | -17.53% -62.05% | -46.20% +451.74% | |
Return on Assets | 108.34% +771.15% | 12.44% +162.33% | -19.95% -48.63% | -38.84% +201.06% | |
Return on Equity | 185.94% +234.82% | -137.92% -216.14% | 118.75% +116.99% | -699.05% +1,156.52% | |
Revenue Growth | 29.40% -44.93% | 53.38% +2,010.39% | -2.79% -85.62% | -19.43% -151.96% | |
Current Ratio | 2.42 +13.39% | 2.13 +14.53% | 1.86 +4.85% | 1.78 -26.87% | |
Cash Ratio | 0.41 -54.39% | 0.90 +45.65% | 0.62 +64.09% | 0.38 +26.21% | |
Debt-to-Equity Ratio | 0.13 -99.26% | 18.15 +972.30% | -2.08 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.10 -72.03% | 0.36 -28.40% | 0.51 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow